These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8655958)

  • 1. Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event.
    Kubicka S; Trautwein C; Schrem H; Tillmann H; Manns M
    J Hepatol; 1995 Oct; 23(4):412-9. PubMed ID: 8655958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
    Challen C; Lunec J; Warren W; Collier J; Bassendine MF
    Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma.
    Diamantis ID; McGandy C; Chen TJ; Liaw YF; Gudat F; Bianchi L
    J Hepatol; 1994 Apr; 20(4):553-6. PubMed ID: 8051396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation.
    Bourdon JC; D'Errico A; Paterlini P; Grigioni W; May E; Debuire B
    Gastroenterology; 1995 Apr; 108(4):1176-82. PubMed ID: 7698586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 Mutations in human hepatocellular carcinomas from Germany.
    Kress S; Jahn UR; Buchmann A; Bannasch P; Schwarz M
    Cancer Res; 1992 Jun; 52(11):3220-3. PubMed ID: 1317262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y; Hayashi K; Hirohashi S; Sekiya T
    Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A molecular pathological study of p53 gene in hepatocellular carcinoma].
    Zhao P
    Zhonghua Bing Li Xue Za Zhi; 1993 Feb; 22(1):16-8. PubMed ID: 8101139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
    Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
    Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of p53 gene in hepatocellular carcinoma in Taiwan.
    Sheu JC; Huang GT; Lee PH; Chung JC; Chou HC; Lai MY; Wang JT; Lee HS; Shih LN; Yang PM
    Cancer Res; 1992 Nov; 52(21):6098-100. PubMed ID: 1327523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
    Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
    Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.
    Coursaget P; Depril N; Chabaud M; Nandi R; Mayelo V; LeCann P; Yvonnet B
    Br J Cancer; 1993 Jun; 67(6):1395-7. PubMed ID: 8390289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people.
    Ng IO; Srivastava G; Chung LP; Tsang SW; Ng MM
    Cancer; 1994 Jul; 74(1):30-7. PubMed ID: 8004579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutation in HCV-genotype-4 associated hepatocellular carcinoma in Egyptian patients.
    Zekri AR; Bahnassy AA; Madbouly MS; Asaad NY; El-Shehaby AM; Alam El Din HM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):17-29. PubMed ID: 17237848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
    Tanaka S; Toh Y; Adachi E; Matsumata T; Mori R; Sugimachi K
    Cancer Res; 1993 Jun; 53(12):2884-7. PubMed ID: 8389246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
    Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
    World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.